Claim
Search Awardees

Novatarg Theranostics

UEI: KYLKB3UZ5SX8 • CAGE: 7MEJ8

Overview

Awardee Type
Parent
Federal Capability Statement
NOVATARG Theranostics proposes sole source small business innovation research (SBIR) projects to deploy its pioneering, proprietary and patented Two-Dimensional Long-Range Ordering and Clustering (2D L-ROC) platform, to enable (1) rapid, accurate, label-free COVID-19 antibody and antigen testing, and (2) structure-based, COVID-19 therapeutic and vaccine interventions. NOVATARG's advances have the potential to accelerate the U.S. readiness to COVID-19 and other future viral threats for which no effective interventions exist.
Keywords
Pioneering, proprietary and patented, Two-Dimensional Long-Range Ordering and Clustering, (2D L-ROC) platform, rapid, accurate, label-free COVID-19 antibody testing, COVID-19 antigen testing, structure-based COVID-19 therapeutic, Structure-based COVID-19 vaccine, high-sensitivity functional screening, high-sensitivity molecular imaging, membrane protein, ACE2, SARS-CoV-2, spike (S) glycoprotein, envelope(E)protein, membrane (M) protein, Surface Plasmon Resonance (SPR)
SBA Special Equipment
Unique enabling Two-Dimensional Long-Range Ordering and Clustering (2D L-ROC) platform. Integrated with high-sensitivity and high-amplification fluorescence detection of full-length functionally active membrane proteins relevant to their native state. Optimized for integration with Surface Plasmon Resonance for label-free detection. Optimized for novel cryo-electron diffraction for high-resolution characterization of the structure of membrane proteins. Ideally suited for structural and functional screening against ACE2, SARS-CoV-2, spike (S) glycoprotein, envelope(E)protein, membrane (M) protein. Ideally suited for accurate, non-invasive nasopharyngeal, oropharyngeal, and saliva-based COVID-19 testing.
Website
https://www.novatarg.com
Headquarters
Weston, MA
United States
Federal recipient NOVATARG THERANOSTICS, INC (UEI KYLKB3UZ5SX8, CAGE 7MEJ8) is headquartered in Weston MA. Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology). The corporation was founded in January 2015 and federally registered in May 2016.

Federal Registration and Certifications

Legal Name
NOVATARG THERANOSTICS, INC
Division Name
NOVATARG THERANOSTICS, INC.
Division Number
0
UEI
KYLKB3UZ5SX8
CAGE Code
7MEJ8
Primary NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Novatarg Theranostics

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo